The 8th annual PREDiCT: Tumour Models London Summit will return this December (4-6) with a fresh speaker faculty to help you benchmark your oncology model selection strategy and target validation. With the rise of immuno-oncology, model requirements, target validation and the importance of tumour micro-environment are key to clinical success. The 3-days summit will provide you with real world data from a selected model experts, including Merck, MedImmune, Sanofi, Institut Gustave Roussy, Basilea Pharmaceutica and more for practical insights.